Global pharma major Lupin Limited (Lupin) today announced that it has received an “A-” leadership rating from CDP for its outstanding performance in climate change and water security. This rating reflects Lupin's leadership in environmental transparency and performance and underscores the strategic and systematic efforts in its sustainability journey.
CDP is a global non-profit that runs the world’s only independent environmental disclosure system for companies to manage their environmental impact. As the founder of environmental reporting, CDP believes in transparency and the power of data to drive change.
Commenting on this achievement, Ramesh Swaminathan, Executive Director, Global CFO and Head – API Plus SBU, Lupin said, “We are delighted to be recognized by CDP as a leader in corporate sustainability. This recognition underscores our commitment to addressing global environmental challenges through measurable action. We consider CDP scores as a critical aspect in advancing our efforts towards sustainability. Lupin will continue to lead by example, setting new standards and adopting best sustainable practices to serve our communities.”
Lupin's sustainability framework is integral to its business operations, prioritizing environmental stewardship, employee well-being, supply chain sustainability, and patient-centric innovation. By integrating these principles, Lupin is paving the way for a sustainable and equitable future. The 2024 CDP scores of “A-” with regard to Climate and Water, mark a significant development from last year's “B” rating in Climate, and “C” rating in Water.
Lupin has demonstrated significant progress in reducing its carbon footprint through various initiatives. The company has implemented energy-efficient technologies and increased the use of renewable energy sources across its operations. These efforts have not only reduced greenhouse gas emissions but also set a benchmark for the pharmaceutical industry in terms of environmental responsibility.
Water security is a critical aspect of Lupin's sustainability strategy. The company has adopted comprehensive water management practices, including water recycling and conservation measures. By optimizing water usage and reducing wastage, Lupin ensures the sustainable use of this vital resource, contributing to the overall health of ecosystems and communities.
As Lupin moves forward, it will continue to leverage advanced technologies and forge strategic partnerships to drive continuous improvement and achieve its long-term sustainability objectives.
Earlier this year, Lupin’s S&P Global ESG scores moved to 76 from 69 last year, above the industry average of 30 in the pharmaceuticals sector.
CDP is a global non-profit that runs the world’s only independent environmental disclosure system for companies to manage their environmental impact. As the founder of environmental reporting, CDP believes in transparency and the power of data to drive change.
Commenting on this achievement, Ramesh Swaminathan, Executive Director, Global CFO and Head – API Plus SBU, Lupin said, “We are delighted to be recognized by CDP as a leader in corporate sustainability. This recognition underscores our commitment to addressing global environmental challenges through measurable action. We consider CDP scores as a critical aspect in advancing our efforts towards sustainability. Lupin will continue to lead by example, setting new standards and adopting best sustainable practices to serve our communities.”
Lupin's sustainability framework is integral to its business operations, prioritizing environmental stewardship, employee well-being, supply chain sustainability, and patient-centric innovation. By integrating these principles, Lupin is paving the way for a sustainable and equitable future. The 2024 CDP scores of “A-” with regard to Climate and Water, mark a significant development from last year's “B” rating in Climate, and “C” rating in Water.
Lupin has demonstrated significant progress in reducing its carbon footprint through various initiatives. The company has implemented energy-efficient technologies and increased the use of renewable energy sources across its operations. These efforts have not only reduced greenhouse gas emissions but also set a benchmark for the pharmaceutical industry in terms of environmental responsibility.
Water security is a critical aspect of Lupin's sustainability strategy. The company has adopted comprehensive water management practices, including water recycling and conservation measures. By optimizing water usage and reducing wastage, Lupin ensures the sustainable use of this vital resource, contributing to the overall health of ecosystems and communities.
As Lupin moves forward, it will continue to leverage advanced technologies and forge strategic partnerships to drive continuous improvement and achieve its long-term sustainability objectives.
Earlier this year, Lupin’s S&P Global ESG scores moved to 76 from 69 last year, above the industry average of 30 in the pharmaceuticals sector.
